images (3)

canon rebel t3

The natural physiological intestinal microflora can be significantly compromised by external influences such as antibiotic therapy, radiation, surgery on the stomach, and also due to improper or unusual food, water changes, climate change and other canon rebel t3 conditions.

Fort regulates balance of intestinal microflora and normalizes its structure. Owing to its composition Fort exchange of normal microflora of the products, the drug helps restore normal intestinal microflora biological way and saves physiological and biological functions of the intestinal mucosa.

Included in the biosynthetic  forte lactic acid and its buffer salts restore normal acidity value in the gastro-intestinal tract independently of whether the patient suffers from high or low acidity. Against the background of accelerating the development of normal intestinal symbionts under the influence canon rebel t3 normalized natural synthesis of  fort short-volatile fatty acids provide restoration of damaged intestinal microflora in infectious diseases of the gastrointestinal tract, stimulates the regeneration of the epithelial cells of the intestinal wall, restoring the disturbed water and electrolyte balance in the intestinal lumen.

There is evidenceenhances the protective functions of the body by stimulating the immune response.

When using forte marked acceleration of excretion of  in infants after salmonella enteritis, which is caused by the stimulation of the growth of the anaerobic intestinal flora acidophilus and its subsequent antagonistic .


Indications for use:

  • violation of the physiological flora canon rebel t3 of the small and large intestines (during and after treatment with antibiotics or sulfonamides, radiotherapy);
  • failure digestive syndrome, dyspepsia;
  • diarrhea, flatulence, constipation;
  • gastroenteritis, colitis; senile bowel syndrome (chronic, atrophic gastroenteritis);
  • disorders of the gastrointestinal tract caused by climate change; hypo- and anatsidnyh state;
  • enterogenous diseases of the gallbladder and liver;
  • allergic skin diseases (urticaria, endogenously caused chronic eczema);
  • salmonellosis in convalescence (including infants).



  • hypersensitivity to the drug.

Use during pregnancy and lactation:
Use of  forte during pregnancy and lactation is considered safe. However, the decision on the appointment of the drug takes the doctor.


Dosage and administration:

Hilak fort is taken orally before or during a meal, diluting a small amount of liquid (except milk).

The drug is administered 3 times a day:

  • Adults: 40-60 drops to a reception;
  • children: 20-40 drops per reception;
  • Infants: 15-30 drops canon rebel t3to a reception.

After improving the daily dose can be reduced by half.


Side effect:

Hilak forte is well tolerated by patients of any age.
Side effects to date have not been observed.
Allergic reactions (skin rash, pruritus, urticaria); constipation, diarrhea.

images (5)

rebel t3

In accordance with the rules existing , rebel t3 may be administered at the same time (in one day) with other vaccines, as well as inactivated vaccines on the immunization schedule epidemic indications. Thus drugs must be administered in different syringes at different sites.
As in the case of other vaccines, it can be expected that in patients receiving immunosuppressive therapy, an adequate immune response may not be achieved.

Special instructions.
In connection with the possibility of development in the very rare cases of anaphylactic reaction, graft should be under medical supervision for 30 minutes, and treatment rooms should be provided with means of anti-shock therapy.  Under no circumstances be administered intravenously! Although the introduction may cause slight immune response to the tetanus toxoid, its introduction can not replace vaccination against tetanus. In subjects who received rebel t3 , is an allocation of the capsular polysaccharide with the urine, so the antigen determination in urine for 1 to 2 weeks after vaccination has no diagnostic value in suspected rebel t3 infection. It is necessary to take into account the potential risk of apnea and the need to monitor respiratory function for 48-72 hours during the course of primary vaccination of children born prematurely (≤ 28 weeks of gestation) and especially infants with respiratory distress syndrome. Given the need for vaccination of children in this group, the vaccine should not be delayed or denied in its conduct. Introduction should be postponed in persons with acute febrile condition. However, slight signs of respiratory infection is not a contraindication to vaccination. HIV infection is not a contraindication to the introduction . total gym bodybuilding 2500/10 bodybuilders over 60

images (6)


Hypersensitivity to components of the vaccine, including tetanus toxoid; the development of allergic reactions to vaccines preceded the introduction.
Acute infectious and non-communicable diseases, exacerbation of chronic diseases (vaccination is carried out within 1 month after recovery). In milder forms of respiratory, intestinal and other infections grafting can be performed after the normalization of temperature.
HIV infection is not a contraindication to the use of t3 .

. Dosage and administration 6 weeks – 6 months : at the beginning of the vaccination until 6 months of age, the course consists of three vaccinations at intervals of 1 month (2, 3, 4 or 3, 4, 5 months of life), or 1.5 months (3 , 4.5, 6 months) or 2 months between doses (2, 4, and 6 months). Vaccination scheme may vary from country to country; in the Russian Federation beginning of vaccination against Haemophilus influenzae type b is provided with 3 months of age.Revaccination is carried out once in the second year of life. Vaccination is recommended together with vaccination against poliomyelitis, t3 whooping cough, diphtheria and tetanus. In this regard, according to the National Immunization Schedule of the Russian Federation, the preferred scheme of 3, 4.5, 6 months, with a booster at 18 months. 6 months – 12 months: at the start of vaccination, after 6 months of age, the course consists of two vaccinations with an interval 1 month. Revaccination is carried out once in the second year of life. For example, vaccination at 6 and 7 months of life and a booster at 18 months of age.

The vaccine can be administered simultaneously with t3 vaccination against poliomyelitis, diphtheria, pertussis, tetanus, measles, mumps and rubella 1 year – 5 years:at the beginning of the vaccination after 1 year the vaccine is administered only once. The vaccine is administered intramuscularly. Patients with thrombocytopenia or other disorders of the blood coagulation system of the vaccine is administered subcutaneously. The solvent should be inspected before use for the presence of foreign matter and the physical properties of the solution. In the presence of foreign particles or change the appearance of the solution it should not be used. Immediately before use in a vaccine vial attached contribute solvent at 0.5 ml per dose. The vial was shaken well to dissolve contents. Lyophilisate normally dissolves within 1 min. The dissolved product is a clear, colorless liquid. If it is different, as well as the presence of foreign particles not vaccine use. A new needle should be used for administration. When using the vaccine in multidose packaging for taking the drug each time a new sterile syringe and needle should be used. The drug should be removed from the vial under strict aseptic technique to prevent contamination of the contents. The preparation of opening the bottle should be used within one working day.

. Adverse Reactions Clinical Studies The t3 reactions at the injection site: Within 48 hours after administration of the vaccine are possible: a slight redness disappear spontaneously; Slight swelling and soreness at the injection site. Common reactions: Within 48 hours after administration of the vaccine may develop fever, loss of appetite, restlessness, vomiting, diarrhea and unusual crying. These general reactions were also recorded when a combination of the introduction of other vaccines. Postmarketing surveillance The following adverse reactions were recorded at a frequency of <000 1/10 (very rare).Immune system : allergic reactions (including anaphylactic and anaphylactoid reactions), angioedema. From the nervous system: hypotonic-hyporesponsiveness episode, seizures (febrile or not), syncope or vasovagal responses to injection, somnolence. respiratory system, organs of the chest and mediastinum: apnea t3. skin and subcutaneous tissue: urticaria, rash. General and local reactions: common limb swelling in the area of administration, the seal at the injection site.

reverse t3

From the digestive system: diarrhea (5%), nausea (3%), abdominal pain (3%); 1% or less – dyspepsia, flatulence, vomiting, melena, cholestatic jaundice, increased activity of “liver” transaminases; in children – constipation, anorexia, gastritis.
In very rare cases: oral reverse t3 candidiasis.
Cardio-vascular system: palpitation, chest pain (1% or less).
From the nervous system: dizziness, headache, vertigo, drowsiness; in children – a headache (in the treatment of otitis media), hyperkinesia, anxiety, neurosis, insomnia (1% or less).
From the urogenital system: vaginal candidiasis, nephritis (1% or less).
Allergic reactions: rash, photosensitivity, . angioedema
Other: fatigue; in children – conjunctivitis, itching, hives.

symptoms: severe nausea, temporary hearing loss, vomiting, diarrhea.
Treatment: symptomatic; gastric lavage.

Interaction with other medicines
Antacids (aluminum and magnesium-containing), ethanol and food slow down and reduce the absorption. The joint appointment of warfarin and reverse t3 azithromycin (in normal doses) changes in prothrombin time is not revealed, however, given that the interaction of macrolides and warfarin may increase the anticoagulant effect, patients requires careful monitoring of the prothrombin time. Digoxin: increase in the concentration of digoxin. Ergotamine and dihydroergotamine: increased toxic effect (vasospasm, dysesthesia). Triazolam: decrease in clearance and an increase in the pharmacological action of triazolam.

Slows down and increases the plasma concentration and toxicity of cycloserine, indirect anticoagulants, methylprednisolone, felodipine and drugs undergoing microsomal oxidation (carbamazepine, terfenadine, cyclosporine, geksobarbital, ergot alkaloids, valproic acid, disopyramide, bromocriptine, phenytoin, oral hypoglycemic agents, theophylline and other xanthine derivatives.) – by inhibiting microsomal oxidation in hepatocytes azithromycin. Linkozaminy weaken the effectiveness of tetracycline and chloramphenicol – increase. Pharmaceutically compatible with heparin.

must be observed to break 2 hours, while the use of antacids. After discontinuation of treatment hypersensitivity reactions in some patients may persist, which requires specific therapy under medical supervision. When you miss receiving 1 dose of the drug missed dose should be taken as soon as possible, and the next – with an interval of 24 hours.

Product form
Powder for oral suspension reverse t3 100 mg / 5 ml. 11.43 g of powder in a bottle of dark glass, a sealed metal lid to control the first opening. Bottle with measuring spoon (5 ml, at the risk of volume 2.5 ml) and instructions for use in paper cartons.